STICHTING VUMC -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:300-400
Total Number of Projects:200-300
2019
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
2018
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:700-800
Total Number of Projects:700-800
Networking Rank (Reputation):100-200
2017
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Networking Rank (Reputation):300-400
2016
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):500-600

Ranking timeline:

Project Participation Performance(2016-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 85
As coordinator: 14
As participant: 64
Sole participant: 7
Coordinator / Participant Ratio: 0.22*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 203.464 43.671.957 3.517.728 1 8
2021 7.832.226 67.809.575 7.484.613 2 13
2020 6.619.072 49.825.857 5.810.830 6 9
2019 22.176.012 102.675.617 13.460.793 4 14
2018 6.527.723 4.250.370 2.055.111 2 2
2017 5.407.488 50.188.027 2.853.901 2 4
2016 18.344.566 62.382.604 10.689.862 4 14

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE13
STICHTING VU12
JANSSEN PHARMACEUTICA NV11
KAROLINSKA INSTITUTE11
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM10
KATHOLIEKE UNIVERSITEIT LEUVEN10
UNIVERSITEIT GENT9
ACADEMISCH ZIEKENHUIS GRONINGEN8
NOVARTIS PHARMA8
UNIVERSITY COLLEGE LONDON8
UNIVERSITY OF OSLO8
REGION HOVEDSTADEN7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
UNIVERSITY OF CAMBRIDGE7
CHARITE UNIVERSITAETSMEDIZIN BERLIN6
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V6
KING'S COLLEGE LONDON6
PFIZER LIMITED6
STICHTING LYGATURE6
UNIVERSITAIR MEDISCH CENTRUM UTRECHT6
UNIVERSITE DE GENEVE6
UNIVERSITY OF HELSINKI6
VRIJE UNIVERSITEIT BRUSSEL6
ALZHEIMER EUROPE5
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM5
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS5
EUROPEAN CANCER PATIENT COALITION5
EUROPEAN MOLECULAR BIOLOGY LABORATORY5
F HOFFMANNLA ROCHE5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
MEDIZINISCHE UNIVERSITAET WIEN5
TAKEDA DEVELOPMENT CENTRE EUROPE5
TAKEDA PHARMACEUTICALS INTERNATIONAL5
THE UNIVERSITY OF NOTTINGHAM5
UNIVERSITY OF COPENHAGEN5
UNIVERSITY OF NEWCASTLE UPON TYNE5
UPPSALA UNIVERSITET5
VIB VZW5
ACADEMIC MEDICAL CENTRE AMSTERDAM4
BAYER4
CENTRE DE REGULACIO GENOMICA4
ELI LILLY AND COMPANY LIMITED4
EUREC OFFICE GUG4
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS4
MASARYKOVA UNIVERZITA4
OSPEDALE PEDIATRICO BAMBINO GESU4
STICHTING RADBOUD UNIVERSITEIT4
SVEUCILISTE U SPLITU MEDICINSKI FAKULTET4
TARTU ULIKOOL4
UNIVERSITAETSKLINIKUM FREIBURG4
UNIVERSITE DU LUXEMBOURG4
UNIVERSITEIT MAASTRICHT4
UNIVERSITY OF BOLOGNA4
VRIJE UNIVERSITEIT AMSTERDAM VERENIGING VOOR CHRISTELIJK WETENSCHAPPELIJK ONDERWIJS4
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG3
CARL ZEISS3
CELGENE MANAGEMENT SARL3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
CENTRO DE INVESTIGACION BIOMEDICA EN RED3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
CONSIGLIO NAZIONALE DELLE RICERCHE3
EATRIS ERIC3
EUROPEAN HEMATOLOGY ASSOCIATION3
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA3
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON3
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA3
GMV SOLUCIONES GLOBALES INTERNET SAU3
GOETEBORGS UNIVERSITET3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT3
H LUNDBECK AS3
LEIDEN UNIVERSITY3
LEIDS UNIVERSITAIR MEDISCH CENTRUM3
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
NATIONAL TECHNICAL UNIVERSITY OF ATHENS3
NOVO NORDISK3
OSLO UNIVERSITETSSYKEHUS HF3
PROVINCIA LOMBARDO VENETA ORDINEOSPEDALIERO DI SAN GIOVANNI DI DIO FATEBENEFRATELLI3
RUPRECHT KARLS UNIVERSITAET HEIDELBERG3
SANOFIAVENTIS3
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL3
TERVEYDEN JA HYVINVOINNIN LAITOS3
THE UNIVERSITY OF EDINBURGH3
THE UNIVERSITY OF MANCHESTER3
UNIVERSIDAD DE NAVARRA3
UNIVERSITA CATTOLICA DEL SACRO CUORE3
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA3
UNIVERSITA DEGLI STUDI DI TORINO3
UNIVERSITAET ULM3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT3
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ3
UNIVERSITATSKLINIKUM BONN3
UNIVERSITEIT UTRECHT3
UNIVERZA V LJUBLJANI3
UNIWERSYTET JAGIELLONSKI3
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER3
ABBVIE INC2
ACADEMISCH ZIEKENHUIS LEIDEN2
AGE PLATFORM EUROPE2

Constancy:

Total number of partners: 1197
Partner loyalty:
Frequent Partner: (> 2 projects): 451
Rare Partner: 746
Frequent / Rare Partner Ratio: 0.6

Project overview:

Start dateProjectacronymrolefundingpartners
2022-10-01improving Research Ethics Expertise and Competences to Ensure Reliability and Trust in Science iRECSparticipant3.794.37418
2022-09-01Moral residue - epistemological ramifications, ethical implications and didactic opportunities MOREparticipant2.455.2634
2022-09-01Implementation and evaluation of a Navigation Intervention for People with Cancer in Old Age and their Family Caregivers: an international pragmatic randomized controlled trial EU NAVIGATEparticipant5.993.22212
2022-09-01A PeRsOnalized Prevention roadmap for the future HEalThcare PROPHETparticipant2.812.43720
2022-09-01Pro-active Pandemic Crisis Ethics and Integrity Framework PREPAREDparticipant4.201.75916
2022-08-01INnoVAtive Solution for Imaging of Infiltrating mONocytes INVASIIONcoordinator203.4641
2022-07-01eBRAIN-Health - Actionable Multilevel Health Data eBRAIN-Healthparticipant12.436.80520
2022-06-01RNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPY CANCERNAparticipant5.999.38113
2022-05-01VALIDATING AI IN CLASSIFYING CANCER IN REAL-TIME SURGERY CLASSICAparticipant5.978.71611
2021-11-01European platform for neurodegenerative disorders EPNDparticipant9.680.00029
2021-10-01Beyond COVID BY-COVIDparticipant12.000.00053
2021-07-01PI3K/PTEN-related monogenic disease to understand cancer PIPgenparticipant4.099.07511
2021-06-01Individualized CARE for Older Persons with Complex Chronic Conditions at home and in nursing homes I-CARE4OLDcoordinator5.832.53614
2021-06-01Psychiatric Ratings using Intermediate Stratified Markers 2 PRISM 2participant3.980.90615
2021-04-01Tau Pathology in Alzheimer’s disease: Spreading and Resilience TAU-NOWparticipant1.500.0002
2021-04-01POLYRISK - Understanding human exposure and health hazard of micro- and nanoplastic contaminants in our environment POLYRISKparticipant5.991.07815
2021-04-01Non-coding RNA and Intercellular Communication in Cardiac Ageing NICCAcoordinator1.999.6901
2021-03-01A multidisciplinary training network for the bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis GLYTUNESparticipant3.744.22411
2021-03-01Training Network for Optimizing Adoptive T cell Therapy of Cancer T-OPparticipant4.100.95912
2021-03-01Anti-Cancer Light-Controllable Antibody-Peptide Conjugates ALISEparticipant745.2007
2021-02-01Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine TIGERparticipant6.900.0008
2021-01-01Evidence-based co-creation methodology for bridging the implementation gap between knowledge and action in health promotion. Health CASCADEparticipant4.058.1097
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18529
2020-12-01Improving the Preparedness of Health Systems to Reduce Mental Health and Psychosocial Concerns resulting from the COVID-19 Pandemic RESPONDparticipant6.172.02817
2020-11-01Drug discovery screening using human neurons HumanNeuronScreencoordinator150.0001
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62541
2020-10-01Skin Tissue Engineering and Regenerative Medicine: From skin repair to regeneration SkinTERMparticipant3.192.7369
2020-07-01Development of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory distress syndrome (ARDS). Impentriparticipant3.662.9635
2020-06-01Chimeric antigen receptor (CAR) T-cell therapy against solid tumors by targeting the vasculature AngioCARcoordinator175.5721
2020-06-01Beyond 1M Genomes B1MGparticipant4.000.00037
2020-05-01Molecular Imaging of Microglia MIMcoordinator175.5721
2020-04-01Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity EDUC8participant2.100.7029
2020-02-01Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells UNPACK PD-L1coordinator175.5721
2020-01-01Causative mechanisms & integrative models linking early-life-stress to psycho-cardio-metabolic multi-morbidity EarlyCauseparticipant5.997.38114
2020-01-01Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research MATCHcoordinator150.0001
2020-01-01A high-dimensional approach for unwinding immune-metabolic causes of cardiovascular disease-depression multimorbidities TO_AITIONparticipant5.990.51514
2020-01-01RISK-BASED SCREENING FOR CERVICAL CANCER RISCCcoordinator5.792.35511
2020-01-01EXposome Powered tools for healthy living in urbAN SEttings EXPANSEparticipant11.993.90720
2019-11-01Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis MIRIADEcoordinator4.015.37611
2019-10-01Exploitation of the SECRETory pathway for cancer therapy to address European research SECRETparticipant3.915.87212
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imagecoordinator15.000.00023
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-06-01Using CRISPR genome screens and dual transcriptome analyses to dissect host-pathogen interactions in tuberculosis Host-TBcoordinator2.160.9262
2019-06-01Research and Training in Early Life Nutrition to Prevent Disease GROWTHparticipant2.133.1998
2019-05-01Dementia: Intersectorial Strategy for Training and Innovation Network for Current Technology (DISTINCT) DISTINCTparticipant3.998.04810
2019-05-01Saracatinib Trial tO Prevent FOP STOPFOPcoordinator999.7106
2019-05-01ENdoThelial macRophage Alliance In Neuroinflammation ENTRAINparticipant3.664.17420
2019-03-01European network staff eXchange for integrAting precision health in the health Care sysTems ExACTparticipant1.090.20018
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027

overview shows latest 50 from 85 projects (2016-01-01 - 2022-12-31)
A full list of projects can be found here: